Regencell Bioscience Holdings Limited Stock
Equities
RGC
KYG7487R1002
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.41 USD | +2.08% |
|
+14.51% | +49.57% |
| 01/11/25 | Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2025 | CI |
| 31/10/25 | Regencell Bioscience Holdings Limited Auditor Raises 'Going Concern' Doubt | CI |
| Capitalization | 15.53B 13.21B 12.24B 11.44B 21.33B 1,427B 22.61B 140B 55.55B 674B 58.24B 57.05B 2,451B | P/E ratio 2024 |
-10.2x | P/E ratio 2025 | -2,351x |
|---|---|---|---|---|---|
| Enterprise value | 15.53B 13.21B 12.24B 11.44B 21.32B 1,427B 22.6B 140B 55.54B 674B 58.22B 57.03B 2,450B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
11.18% | Yield 2024 * |
-
| Yield 2025 | - |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 day | +2.08% | ||
| 1 week | +14.51% | ||
| Current month | +49.57% | ||
| 1 month | +24.40% | ||
| 3 months | +96.07% | ||
| 6 months | +112.37% | ||
| Current year | +49.57% |
| 1 week | 20.81 |  | 37.8 |
| 1 month | 19.8 | | 69 |
| Current year | 20.5 | | 69 |
| 1 year | 0.09 | | 83.6 |
| 3 years | 0.08 | | 83.6 |
| 5 years | 0.08 | | 83.6 |
| 10 years | 0.08 | | 83.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yat-Gai Au
CEO | Chief Executive Officer | 54 | 01/01/2014 |
Wai Hong Chung
COO | Chief Operating Officer | 49 | 01/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Wai Hong Chung
BRD | Director/Board Member | 49 | 28/12/2023 |
Yee Wah Hui
BRD | Director/Board Member | 54 | 01/07/2021 |
Wing Yan Lo
BRD | Director/Board Member | 65 | 13/12/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | +14.51% | +24,927.89% | +4,066.34% | 15.53B | |
| +0.04% | -0.68% | -4.77% | +12.20% | 49.48B | |
| -1.56% | -1.00% | +14.23% | +2.87% | 40.07B | |
| +0.15% | +0.33% | +52.68% | +26.14% | 37.55B | |
| +1.92% | +1.44% | +23.10% | +42.46% | 31.67B | |
| -0.99% | -2.20% | +185.93% | +328.06% | 22.74B | |
| -3.01% | -3.74% | +69.03% | +145.51% | 16.56B | |
| Average | -0.20% | +1.69% | +3,609.73% | +660.51% | 30.51B | |
| Weighted average by Cap. | -0.16% | +0.80% | +1,852.01% | +356.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -4.3M -3.66M -3.39M -3.17M -5.91M -395M -6.26M -38.76M -15.39M -187M -16.13M -15.8M -679M | -3.58M -3.05M -2.83M -2.64M -4.92M -329M -5.22M -32.29M -12.82M -155M -13.44M -13.16M -566M |
| Net Debt | -7.88M -6.7M -6.21M -5.8M -10.82M -724M -11.46M -70.95M -28.17M -342M -29.53M -28.93M -1.24B | -4.35M -3.7M -3.43M -3.21M -5.98M -400M -6.34M -39.21M -15.57M -189M -16.32M -15.99M -687M |
More financial data
* Estimated data
Employees
10
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 31.41 $ | +2.08% | 1,163,409 |
| 22/01/26 | 30.77 $ | +40.44% | 1,320,309 |
| 21/01/26 | 21.91 $ | -9.91% | 338,156 |
| 20/01/26 | 24.32 $ | -11.34% | 361,371 |
| 16/01/26 | 27.43 $ | -8.75% | 362,165 |
Delayed Quote Nasdaq, 24 January 2026 at 08:00 am AEDT
More quotes
- Stock Market
- Equities
- RGC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition